DAVITA INC. Equity Securities, FV-NI, Unrealized Loss
DAVITA INC. (DVA) reported Equity Securities, FV-NI, Unrealized Loss of $10.31 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-10-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesFvNiUnrealizedLoss · last filed 2021-10-28
- DAVITA INC. equity securities, fv-ni, unrealized loss for the quarter ending 2021-09-30 was $10.31M.
| Period end | Equity Securities, FV-NI, Unrealized Loss 3 month | Equity Securities, FV-NI, Unrealized Loss 9 month |
|---|---|---|
| 2021-09-30 | $10.31M 10-Q · filed 2021-10-28 | $1.99M 10-Q · filed 2021-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |